Imaging mass spectrometry analysis reveals an altered lipid distribution pattern in the tubular areas of hyper-IgA murine kidneys

Experimental and Molecular Pathology

Volumn 91, Issue 2, 2011, Pages 614-621

  Kaneko, Yukihiro ^a   Obata, Yoko ^b   Nishino, Tomoya ^b   Kakeya, Hiroshi ^b   Miyazaki, Yoshitsugu ^a   Hayasaka, Takahiro ^c   Setou, Mitsutoshi ^c   Furusu, Akira ^b   Kohno, Shigeru ^b  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Deposition; IgA; Imaging mass spectrometry; Lipid; Molecular distribution; Molecular imaging; Nephropathy; Phosphatidylcholine; Urinary stagnation; Urine

Indexed keywords

IMMUNOGLOBULIN A; PHOSPHATIDYLCHOLINE; TRIACYLGLYCEROL;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; IMAGE ANALYSIS; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN DEPOSITION; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY TUBULE; LIPID ANALYSIS; LIPID COMPOSITION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MOLECULAR IMAGING; MOLECULAR WEIGHT; MOUSE; NONHUMAN; URETHRA OBSTRUCTION; URINALYSIS;

ANIMALS; GLOMERULONEPHRITIS, IGA; IMAGING, THREE-DIMENSIONAL; KIDNEY CORTEX; KIDNEY TUBULES; LIPID METABOLISM; MICE; MOLECULAR WEIGHT; PHOSPHATIDYLCHOLINES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRIGLYCERIDES;

ANIMALIA; MURINAE; MUS;

EID: 79961108152     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2011.07.002     Document Type: Article

References (19)

1. Baronas E.T., Lee J.W., Alden C., Hsieh F.Y. Biomarkers to monitor drug-induced phospholipidosis. Toxicol. Appl. Pharmacol. 2007, 218:72-78.
2. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 1959, 37:911-917.
3. Coppo R., Fonsato V., Balegno S., Ricotti E., Loiacono E., Camilla R., Peruzzi L., Amore A., Bussolati B., Camussi G. Aberrantly glycosylated IgA1 induces mesangial cells to produce platelet-activating factor that mediates nephrin loss in cultured podocytes. Kidney Int. 2010, 77:417-427.
4. Drummond S.P., Allen T.D. From live-cell imaging to scanning electron microscopy (SEM): the use of green fluorescent protein (GFP) as a common label. Methods Cell Biol. 2008, 88:97-108.
5. Grunkin M., Raundahl J., Foged N.T. Practical considerations of image analysis and quantification of signal transduction IHC staining. Methods Mol. Biol. 2011, 717:143-154.
6. Hayasaka T., Goto-Inoue N., Sugiura Y., Zaima N., Nakanishi H., Ohishi K., Nakanishi S., Naito T., Taguchi R., Setou M. Matrix-assisted laser desorption/ionization quadrupole ion trap time-of-flight (MALDI-QIT-TOF)-based imaging mass spectrometry reveals a layered distribution of phospholipid molecular species in the mouse retina. Rapid Commun. Mass Spectrom. 2008, 22:3415-3426.
7. Iijima Y., Nakamura Y., Ogata Y., Tanaka K., Sakurai N., Suda K., Suzuki T., Suzuki H., Okazaki K., Kitayama M., Kanaya S., Aoki K., Shibata D. Metabolite annotations based on the integration of mass spectral information. Plant J. 2008, 54:949-962.
8. Kurashige T., Abe K., Furusu A., Miyazaki M., Obata Y., Xia Z., Nakazawa M., Nakazawa Y., Funakoshi S., Harada T., Koji T., Kohno S. Renoprotective effect of azelnidipine in rats. Biol. Pharm. Bull. 2008, 31:2237-2244.
9. Li L., Zepeda-Orozco D., Black R., Lin F. Autophagy is a component of epithelial cell fate in obstructive uropathy. Am. J. Pathol. 2010, 176:1767-1778.
10. Mimura K., Zhao B., Muguruma K., Frenkel R.A., Johnston J.M. Changes in glycerophospholipid profile in experimental nephrotic syndrome. Metabolism 1996, 45:822-826.
11. Muda A.O., Feriozzi S., Rahimi S., Faraggiana T. Spatial arrangement of IgA and C3 as prognostic indicator of IgA nephropathy. J. Pathol. 1995, 177:201-208.
12. Muso E., Yoshida H., Takeuchi E., Yashiro M., Matsushima H., Oyama A., Suyama K., Kawamura T., Kamata T., Miyawaki S., Izui S., Sasayama S. Enhanced production of glomerular extracellular matrix in a new mouse strain of high serum IgA ddY mice. Kidney Int. 1996, 50:1946-1957.
13. Robinson D.R., Tateno S., Patel B., Hirai A. Dietary marine lipids after the course of autoimmune disease. Prog. Clin. Biol. Res. 1988, 282:295-303.
14. Setou M., Kurabe N. Mass microscopy: high-resolution imaging mass spectrometry. J. Electron Microsc. (Tokyo) 2011, 60:47-56.
15. Sugiura Y., Setou M. Selective imaging of positively charged polar and nonpolar lipids by optimizing matrix solution composition. Rapid Commun. Mass Spectrom. 2009, 23:3269-3278.
16. Willems S.M., van Remoortere A., van Zeijl R., Deelder A.M., McDonnell L.A., Hogendoorn P.C. Imaging mass spectrometry of myxoid sarcomas identifies proteins and lipids specific to tumour type and grade, and reveals biochemical intratumour heterogeneity. J. Pathol. 2010, 222:400-409.
17. Yasuda Y., Cohen C.D., Henger A., Kretzler M. The European Renal cDNA Bank (ERCB) Consortium: Gene expression profiling analysis in nephrology: towards molecular definition of renal disease. Clin. Exp. Nephrol. 2006, 10:91-98.
18. Yoshioka Y., Tsutsumi T., Adachi M., Tokumura A. Altered phospholipid profile in urine of rats with unilateral ureteral obstruction. Metabolomics 2009, 5:429-433.
19. Zhang H., Saha J., Byun J., Schin M., Lorenz M., Kennedy R.T., Kretzler M., Feldman E.L., Pennathur S., Brosius F.C. Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2008, 295:F1071-F1081.